Related Experiment Video
Updated: Jun 12, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential
Swapna Panuganti1, Eleftherios T Papoutsakis, William M Miller
1Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208, USA.
Background Aims:
Megakaryopoiesis encompasses hematopoietic stem and progenitor cell (HSPC) commitment to the megakaryocytic cell (Mk) lineage, expansion of Mk progenitors and mature Mks, polyploidization and platelet release. pH and pO2 increase from the endosteum to sinuses, and different cytokines are important for various stages of differentiation. We hypothesized that mimicking the changing conditions during Mk differentiation in the bone marrow would facilitate expansion of progenitors that could generate many high-ploidy Mks.
Methods:
CD34+ HSPCs were cultured at pH 7.2 and 5% O2 with stem cell factor (SCF), thrombopoietin (Tpo) and all combinations of Interleukin (IL)-3, IL-6, IL-11 and Flt-3 ligand to promote Mk progenitor expansion. Cells cultured with selected cytokines were shifted to pH 7.4 and 20% O2 to generate mature Mks, and treated with nicotinamide (NIC) to enhance polyploidization.
Results:
Using Tpo + SCF + IL-3 + IL-11, we obtained 3.5 CD34+ CD41+ Mk progenitors per input HSPC, while increasing purity from 1% to 17%. Cytokine cocktails with IL-3 yielded more progenitors and mature Mks, although the purities were lower. Mk production was much greater at higher pH and pO2. Although fewer progenitors were present, shifting to 20% O2 /pH 7.4 at day 5 (versus days 7 or 9) yielded the greatest mature Mk production, 14 per input HSPC. NIC more than doubled the percentage of high-ploidy Mks to 40%.
Conclusions:
We obtained extensive Mk progenitor expansion, while ensuring that the progenitors could produce high-ploidy Mks. We anticipate that subsequent optimization of cytokines for mature Mk production and delayed NIC addition will greatly increase high-ploidy Mk production.
Insights
Mimicking bone marrow conditions expanded megakaryocyte (Mk) progenitors and produced more mature Mks. Nicotinamide treatment increased high-ploidy Mk production, paving the way for enhanced platelet generation.
Area of Science:
- Hematology
- Cell Biology
- Stem Cell Research
Background:
- Megakaryopoiesis is a complex process involving hematopoietic stem and progenitor cell (HSPC) differentiation into megakaryocytes (Mk) and subsequent platelet production.
- Bone marrow microenvironment conditions, including pH and oxygen levels, dynamically change during Mk differentiation.
- Existing methods for Mk expansion often do not fully replicate these physiological gradients, potentially limiting progenitor expansion and maturation.
Purpose of the Study:
- To investigate if mimicking the changing pH and pO2 gradients of the bone marrow can enhance Mk progenitor expansion and the generation of high-ploidy Mks.
- To optimize cytokine combinations and culture conditions for efficient Mk production.
- To assess the effect of nicotinamide (NIC) on enhancing Mk polyploidization.
Main Methods:
- CD34+ HSPCs were cultured under specific conditions (pH 7.2, 5% O2) with combinations of stem cell factor (SCF), thrombopoietin (Tpo), and interleukins (IL-3, IL-6, IL-11), and Flt-3 ligand.
- Cells were subsequently shifted to higher pH (7.4) and oxygen (20% O2) to promote Mk maturation.
- Nicotinamide (NIC) was used to enhance polyploidization of mature Mks.
Main Results:
- A cytokine cocktail (Tpo + SCF + IL-3 + IL-11) significantly increased Mk progenitor expansion (3.5-fold) and purity (17%).
- Culture conditions involving higher pH and pO2, particularly a shift at day 5, maximized mature Mk production (14-fold per input HSPC).
- Nicotinamide treatment more than doubled the proportion of high-ploidy Mks to 40%.
Conclusions:
- The study successfully demonstrated extensive Mk progenitor expansion and generation of high-ploidy Mks by mimicking bone marrow microenvironment conditions.
- Optimizing cytokine combinations and the timing of environmental shifts is crucial for efficient Mk production.
- Further refinement of NIC addition timing and cytokine selection holds promise for significantly increasing high-ploidy Mk yields for therapeutic applications.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Multipotency of Hematopoietic Stem Cells
Lineage Commitment
Production of Formed Elements
Most HSCs commit to...
Hematopoiesis

